StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Total U.S. Industry FDA PMA & Supplements Approvals by Month

Total U.S. Industry FDA PMA & Supplements Approvals (U.S. Industry Total)

Thermo Fisher Scientific Total U.S. Industry FDA PMA & Supplements Approvals: 187 in Sep 2026, down 7.0% from a year earlier.

Latest, Sep 2026
187
Period ended Sep 30, 2026
Change on a year earlier
-7.0%
201 in Sep 2025
History
129 months
Since Jan 2016
Sources
1
openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total

Where the Sep 2026 figure comes from

Source: openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗

Reported in U.S. FDA openFDA Premarket Approval (PMA) API.

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal U.S. Industry FDA PMA & Supplements Approvals (U.S. Industry Total)Year on yearSource
Sep 2026Sep 30, 2026187-7.0%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Aug 2026Aug 31, 2026160-13.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Jul 2026Jul 31, 2026218+9.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Jun 2026Jun 30, 2026185-15.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
May 2026May 31, 2026213+19.0%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Apr 2026Apr 30, 2026210+10.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Mar 2026Mar 31, 20261780.0%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Feb 2026Feb 28, 2026253+29.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Jan 2026Jan 31, 2026136-9.3%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Dec 2025Dec 31, 2025218-9.5%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Nov 2025Nov 30, 202580-63.0%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Oct 2025Oct 31, 2025227+0.4%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Sep 2025Sep 30, 2025201+14.9%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Aug 2025Aug 31, 2025185+10.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Jul 2025Jul 31, 2025199+2.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗
Jun 2025Jun 30, 2025219+28.1%openFDA Premarket Approvals (PMA & Supplements) — U.S. Device Industry Total ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Total U.S. Industry FDA PMA & Supplements Approvals, monthly Jan 2016–Sep 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fda-pma-industry

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.